{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T05:25:36Z","timestamp":1775885136766,"version":"3.50.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ogc.2018.01.008","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T23:34:50Z","timestamp":1521416090000},"page":"201-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Opioid Use Disorders and Pregnancy"],"prefix":"10.1016","volume":"45","author":[{"given":"Amanda J.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cresta W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"50\u201351","key":"10.1016\/j.ogc.2018.01.008_bib1","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths \u2013 United States, 2000-2014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ogc.2018.01.008_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.drugalcdep.2017.01.003","article-title":"Non-medical opioid use and sources of opioids among pregnant and non-pregnant reproductive-aged women","volume":"174","author":"Kozhimannil","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.ogc.2018.01.008_bib3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.whi.2017.03.001","article-title":"Nonmedical use of prescription opioids among pregnant U.S. women","volume":"27","author":"Kozhimannil","year":"2017","journal-title":"Womens Health Issues"},{"issue":"8","key":"10.1016\/j.ogc.2018.01.008_bib4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/jp.2015.36","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012","volume":"35","author":"Patrick","year":"2015","journal-title":"J\u00a0Perinatol"},{"issue":"9","key":"10.1016\/j.ogc.2018.01.008_bib5","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/add.13842","article-title":"The economic burden of neonatal abstinence syndrome in the United States","volume":"112","author":"Corr","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.ogc.2018.01.008_bib6","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"issue":"3","key":"10.1016\/j.ogc.2018.01.008_bib7","doi-asserted-by":"crossref","first-page":"255.e1-4","DOI":"10.1016\/j.ajog.2014.03.023","article-title":"Prevalence of illicit drug use in pregnant women in a Wisconsin private practice setting","volume":"211","author":"Schauberger","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2018.01.008_bib8","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"ACOG practice bulletin no. 711. Opioid use and opioid use disorder in pregnancy","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2018.01.008_bib9","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.AOG.0000466371.86393.9b","article-title":"ACOG committee opinion no. 633. Alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.ogc.2018.01.008_bib10","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/sj.jp.7211823","article-title":"Validation of the 4Ps plus screen for substance use in pregnancy validation of the 4Ps plus","volume":"27","author":"Chasnoff","year":"2007","journal-title":"J\u00a0Perinatol"},{"issue":"4","key":"10.1016\/j.ogc.2018.01.008_bib11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ajog.2013.10.010","article-title":"Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers","volume":"210","author":"Jones","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2018.01.008_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/AOG.0000000000002054","volume":"130","author":"Reddy","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2018.01.008_bib13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ajog.2016.06.038","article-title":"The role of screening, brief intervention, and referral to treatment in the perinatal period","volume":"215","author":"Wright","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2018.01.008_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ogc.2014.02.005","article-title":"Buprenorphine and methadone for opioid addiction during pregnancy","volume":"41","author":"Mozurkewich","year":"2014","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ogc.2018.01.008_bib15","series-title":"A\u00a0collaborative approach to the treatment of pregnant women with opioid use disorders","year":"2016"},{"issue":"2","key":"10.1016\/j.ogc.2018.01.008_bib16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-assisted treatment with methadone: assessing the evidence","volume":"65","author":"Fullerton","year":"2014","journal-title":"Psychiatr Serv"},{"issue":"2","key":"10.1016\/j.ogc.2018.01.008_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1176\/appi.ps.201300256","article-title":"Medication-assisted treatment with buprenorphine: assessing the evidence","volume":"65","author":"Thomas","year":"2014","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.ogc.2018.01.008_bib18","series-title":"What is the federal government doing to combat the opioid abuse epidemic?","year":"2015"},{"issue":"24","key":"10.1016\/j.ogc.2018.01.008_bib19","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after\u00a0methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogc.2018.01.008_bib20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.drugalcdep.2013.11.006","article-title":"Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy","volume":"334","author":"Jones","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.ogc.2018.01.008_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000210042","article-title":"Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study","volume":"15","author":"Bakstad","year":"2009","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.ogc.2018.01.008_bib22","doi-asserted-by":"crossref","first-page":"j3326","DOI":"10.1136\/bmj.j3326","article-title":"Risk of neonatal withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study","volume":"358","author":"Huybrechts","year":"2017","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ogc.2018.01.008_bib23","first-page":"358","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.ogc.2018.01.008_bib24","series-title":"Guidelines for identification and management of substance use and substance use disorders in pregnancy","author":"World Health Organization (WHO)","year":"2014"},{"key":"10.1016\/j.ogc.2018.01.008_bib25","unstructured":"Title 21 code of federal regulations. US Drug Enforcement Administration Web site. Available at: http:\/\/deadiversion.usdoj.gov\/21cfr\/cfr\/1306\/1306_07.htm. Accessed September 8, 2017."},{"key":"10.1016\/j.ogc.2018.01.008_bib26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1542\/peds.54.3.300","article-title":"The effect of a methadone treatment program upon pregnant heroin addicts and their newborn infants","volume":"54","author":"Harper","year":"1974","journal-title":"Pediatrics"},{"key":"10.1016\/j.ogc.2018.01.008_bib27","unstructured":"Substance abuse confidentiality regulations. Substance Abuse and Mental Health Services Administration Web. 2016. Available at: http:\/\/www.samhsa.gov\/about-us\/who-we-are\/laws\/confidentiality-regulations-faqs. Accessed August 10, 2017."},{"issue":"1\u20132","key":"10.1016\/j.ogc.2018.01.008_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2009.03.020","article-title":"Comparing overdose mortality associated with methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.ogc.2018.01.008_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/AOG.0000000000000640","article-title":"Buprenorphine and naloxone compared with methadone treatment in pregnancy","volume":"125","author":"Wiegand","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2018.01.008_bib30","first-page":"61","article-title":"A\u00a0comparison of buprenorphine\u00a0+ naloxone to buprenorphine and methadone in the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes","volume":"6","author":"Lund","year":"2013","journal-title":"Subst Abuse"},{"issue":"3","key":"10.1016\/j.ogc.2018.01.008_bib31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1521-0391.2012.12005.x","article-title":"Buprenorphine\u00a0+ naloxone compared with methadone treatment during pregnancy \u2013 initial patient care and outcome data","volume":"22","author":"Debelak","year":"2013","journal-title":"Am J Addict"},{"issue":"8","key":"10.1016\/j.ogc.2018.01.008_bib32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/17512433.2017.1336434","article-title":"Buprenorphine implants in medical treatment of opioid addiction","volume":"10","author":"Chavoustie","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ogc.2018.01.008_bib33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/jama.2016.9382","article-title":"Effect of buprenorphine implants on illicit opioid use among abstinent adults with opioid dependence treated with sublingual buprenorphine: a randomized clinical trial","volume":"316","author":"Rosenthal","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ogc.2018.01.008_bib34","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/add.13462","article-title":"Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child","volume":"111","author":"Zedler","year":"2016","journal-title":"Addiction"},{"issue":"12","key":"10.1016\/j.ogc.2018.01.008_bib35","article-title":"Maintenance agonist treatments for opiate-dependent pregnant women","author":"Minozzi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ogc.2018.01.008_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jsat.2011.05.002","article-title":"Changes in methadone maintenance therapy during and after pregnancy","volume":"41","author":"Albright","year":"2011","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"10","key":"10.1016\/j.ogc.2018.01.008_bib37","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00228-005-0035-5","article-title":"Changes to methadone clearance during pregnancy","volume":"61","author":"Wolff","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.ogc.2018.01.008_bib38","doi-asserted-by":"crossref","first-page":"64.e1-7","DOI":"10.1016\/j.ajog.2016.09.095","article-title":"Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy","volume":"216","author":"Bastian","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2018.01.008_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.06.029","article-title":"An evidence-based recommendation to increase the dosing frequency of buprenorphine during pregnancy","author":"Caritis","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2018.01.008_bib40","first-page":"105","article-title":"The effect of methadone dose regimen on neonatal abstinence syndrome","volume":"9","author":"McCarthy","year":"2015","journal-title":"J\u00a0Addict Med"},{"issue":"12","key":"10.1016\/j.ogc.2018.01.008_bib41","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/j.1360-0443.2010.03120.x","article-title":"Methadone dose and neonatal abstinence syndrome \u2013 systematic review and meta-analysis","volume":"105","author":"Cleary","year":"2010","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.ogc.2018.01.008_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000441220","article-title":"Maternal buprenorphine dose at delivery and its relationship to neonatal outcomes","volume":"22","author":"O\u2019Connor","year":"2016","journal-title":"Eur Addict Res"},{"issue":"1","key":"10.1016\/j.ogc.2018.01.008_bib43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/GRF.0b013e31827feea4","article-title":"Neonatal abstinence syndrome: treatment and pediatric outcomes","volume":"56","author":"Logan","year":"2013","journal-title":"Clin Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2018.01.008_bib44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1891\/0730-0832.35.5.277","article-title":"Long-term outcomes of infants with neonatal abstinence syndrome","volume":"35","author":"Maguire","year":"2016","journal-title":"Neonatal Netw"},{"issue":"2","key":"10.1016\/j.ogc.2018.01.008_bib45","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2651","article-title":"Neonatal abstinence syndrome and high school performance","volume":"139","author":"Oei","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.ogc.2018.01.008_bib46","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/0002-9378(73)90953-8","article-title":"Narcotic withdrawal in pregnancy: stillbirth incidence with a case report","volume":"116","author":"Rementeria","year":"1973","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2018.01.008_bib47","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0740-5472(03)00035-7","article-title":"Is opiate detoxification unsafe in pregnancy?","volume":"24","author":"Luty","year":"2003","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"3","key":"10.1016\/j.ogc.2018.01.008_bib48","doi-asserted-by":"crossref","first-page":"374.e1-6","DOI":"10.1016\/j.ajog.2016.03.015","article-title":"Detoxification from opiate drugs during pregnancy","volume":"215","author":"Bell","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2018.01.008_bib49","doi-asserted-by":"crossref","first-page":"267.e1-5","DOI":"10.1016\/j.ajog.2013.05.026","article-title":"The obstetrical and neonatal impact of maternal opioid detoxification in pregnancy","volume":"209","author":"Stewart","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2018.01.008_bib50","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/10550490802266276","article-title":"Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes","volume":"17","author":"Jones","year":"2008","journal-title":"Am J Addict"},{"issue":"2","key":"10.1016\/j.ogc.2018.01.008_bib51","first-page":"90","article-title":"Medically assisted withdrawal (detoxification): considering the mother-infant dyad","volume":"11","author":"Jones","year":"2017","journal-title":"J\u00a0Addict Med"},{"issue":"5","key":"10.1016\/j.ogc.2018.01.008_bib52","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000381670","article-title":"Tapering from methadone or buprenorphine during pregnancy: maternal and neonatal outcomes in Norway 1996-2009","volume":"21","author":"Welle-Strand","year":"2015","journal-title":"Eur Addict Res"},{"issue":"2","key":"10.1016\/j.ogc.2018.01.008_bib53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1360-0443.2012.03811.x","article-title":"Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research","volume":"108","author":"Jones","year":"2013","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.ogc.2018.01.008_bib54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.drugalcdep.2004.02.003","article-title":"A\u00a0randomised, controlled trial of low dose naltrexone for the treatment of opioid dependence","volume":"75","author":"Rea","year":"2004","journal-title":"Drug Alcohol Depend"},{"issue":"7534","key":"10.1016\/j.ogc.2018.01.008_bib55","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/bmj.332.7534.132","article-title":"Naltrexone and problems in pain management","volume":"332","author":"Vickers","year":"2006","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ogc.2018.01.008_bib56","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s40265-017-0762-9","article-title":"A\u00a0retrospective cohort study of obstetric outcomes in opioid-dependent women treated with implant naltrexone, oral methadone or sublingual buprenorphine, and non-dependent controls","volume":"77","author":"Kelty","year":"2017","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.ogc.2018.01.008_bib57","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/sj.jp.7210933","article-title":"Prenatal care reduces the impact of illicit drug use on perinatal outcomes","volume":"23","author":"El-Mohandes","year":"2003","journal-title":"J\u00a0Perinatol"},{"issue":"1","key":"10.1016\/j.ogc.2018.01.008_bib58","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/AOG.0b013e31820a6216","article-title":"ACOG Committee on Health Care for Underserved Women. ACOG committee opinion no. 473. Substance abuse reporting and pregnancy: the role of the obstetrician-gynecologist","volume":"117","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2018.01.008_bib59","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/10550887.2016.1177809","article-title":"Associations between compulsive buying and substance dependence\/abuse, major depressive episodes, and generalized anxiety disorder among men and women","volume":"35","author":"Zhang","year":"2016","journal-title":"J\u00a0Addict Dis"},{"issue":"5","key":"10.1016\/j.ogc.2018.01.008_bib60","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1521-0391.2010.00064.x","article-title":"Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women","volume":"19","author":"Benningfield","year":"2010","journal-title":"Am J Addict"},{"issue":"6","key":"10.1016\/j.ogc.2018.01.008_bib61","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/00952990.2012.696168","article-title":"Co-occurring psychiatric symptoms in opioid-dependent women: the prevalence of antenatal and postnatal depression","volume":"38","author":"Holbrook","year":"2012","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.ogc.2018.01.008_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7517-11-34","article-title":"\u201cLike a lots happened in my whole childhood\u201d: violence, trauma and addiction in pregnant and postpartum women from Vancouver\u2019s Downtown Eastside","volume":"12","author":"Torchalla","year":"2015","journal-title":"Harm Reduct J"},{"issue":"11","key":"10.1016\/j.ogc.2018.01.008_bib63","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.earlhumdev.2007.08.002","article-title":"Epidemiology of prenatal smoking and perinatal outcomes","volume":"83","author":"Salihu","year":"2007","journal-title":"Early Hum Dev"},{"issue":"7","key":"10.1016\/j.ogc.2018.01.008_bib64","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/ntr\/nts274","article-title":"A\u00a0comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine","volume":"15","author":"Chisolm","year":"2013","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.ogc.2018.01.008_bib65","series-title":"Results from the 2012 National survey on drug use and health. Summary of national findings","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2013"},{"key":"10.1016\/j.ogc.2018.01.008_bib66","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jsat.2014.12.002","article-title":"Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review","volume":"52","author":"Akerman","year":"2015","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"3","key":"10.1016\/j.ogc.2018.01.008_bib67","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000216466","article-title":"Association between prenatal tobacco exposure and outcomes of neonates born to opioid-maintained mothers. Implications for treatment","volume":"15","author":"Winklbaur","year":"2009","journal-title":"Eur Addict Res"},{"issue":"3","key":"10.1016\/j.ogc.2018.01.008_bib68","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.drugalcdep.2004.03.012","article-title":"Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure","volume":"75","author":"Choo","year":"2004","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.ogc.2018.01.008_bib69","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugalcdep.2012.11.019","article-title":"Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes","volume":"131","author":"Jones","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"S1","key":"10.1016\/j.ogc.2018.01.008_bib70","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1360-0443.2012.04042.x","article-title":"Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine","volume":"107","author":"Holbrook","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.ogc.2018.01.008_bib71","doi-asserted-by":"crossref","DOI":"10.1007\/s10995-017-2316-x","article-title":"Hepatitis C cascade of care among pregnant women on opioid agonist pharmacotherapy attending a comprehensive prenatal program","author":"Page","year":"2017","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.ogc.2018.01.008_bib72","doi-asserted-by":"crossref","DOI":"10.1093\/pm\/pnw255","article-title":"Opioid-induced constipation and bowel dysfunction: a clinical guideline","author":"Muller-Lissner","year":"2016","journal-title":"Pain Med"},{"issue":"6","key":"10.1016\/j.ogc.2018.01.008_bib73","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4131","article-title":"Maternal use of opioids during pregnancy and congenital malformations: a systematic review","volume":"139","author":"Lind","year":"2017","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ogc.2018.01.008_bib74","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/add.12400","article-title":"Reduced fetal growth in methadone-maintained pregnancies is not fully explained by smoking or socio-economic depravation","volume":"109","author":"Mactier","year":"2014","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.ogc.2018.01.008_bib75","doi-asserted-by":"crossref","first-page":"F258","DOI":"10.1136\/adc.2009.163105","article-title":"Growth restriction in pregnancies of opioid-dependent mothers","volume":"95","author":"Liu","year":"2010","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"5","key":"10.1016\/j.ogc.2018.01.008_bib76","doi-asserted-by":"crossref","first-page":"529.e1-8","DOI":"10.1016\/j.ajog.2017.01.040","article-title":"Maternal buprenorphine treatment and fetal neurobehavioral development","volume":"216","author":"Jansson","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"3 Pt 1","key":"10.1016\/j.ogc.2018.01.008_bib77","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ajog.2005.02.075","article-title":"Fetal response to maternal methadone administration","volume":"193","author":"Jansson","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ogc.2018.01.008_bib78","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.2105\/AJPH.2015.302821","article-title":"Women-centered drug treatment services and need in the United States, 2002-2009","volume":"105","author":"Terplan","year":"2015","journal-title":"Am J Public Health"},{"issue":"3","key":"10.1016\/j.ogc.2018.01.008_bib79","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1080\/10550490600626721","article-title":"Post-cesarean pain management of patients maintained on methadone or buprenorphine","volume":"15","author":"Jones","year":"2006","journal-title":"Am J Addict"},{"issue":"2","key":"10.1016\/j.ogc.2018.01.008_bib80","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/GRF.0000000000000288","article-title":"Peripartum anesthetic management of the opioid-tolerant of buprenorphine\/suboxone-dependent patient","volume":"60","author":"Pan","year":"2017","journal-title":"Clin Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2018.01.008_bib81","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jsgi.2005.11.001","article-title":"Effect of chronic methadone therapy on intrapartum fetal heart rate patterns","volume":"13","author":"Ramirez-Cacho","year":"2006","journal-title":"J\u00a0Soc Gynecol Investig"},{"issue":"2Pt1","key":"10.1016\/j.ogc.2018.01.008_bib82","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.AOG.0000275288.47258.e0","article-title":"Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy","volume":"110","author":"Meyer","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ogc.2018.01.008_bib83","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejpain.2010.03.002","article-title":"Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy","volume":"14","author":"Meyer","year":"2010","journal-title":"Eur J Pain"},{"issue":"2","key":"10.1016\/j.ogc.2018.01.008_bib84","first-page":"103","article-title":"Dosing adjustments in postpartum patients maintained on buprenorphine or methadone","volume":"2","author":"Jones","year":"2008","journal-title":"J\u00a0Addict Med"},{"issue":"2","key":"10.1016\/j.ogc.2018.01.008_bib85","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-144-2-200601170-00010","article-title":"Acute pain management for patients receiving maintenance methadone or buprenorphine therapy","volume":"144","author":"Alford","year":"2006","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ogc.2018.01.008_bib86","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/00952990902825413","article-title":"Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy","volume":"35","author":"Jones","year":"2009","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.ogc.2018.01.008_bib87","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1940-0640-9-19","article-title":"Review of the assessment and management of neonatal abstinence syndrome","volume":"9","author":"Bagley","year":"2014","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"10.1016\/j.ogc.2018.01.008_bib88","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/jmwh.12009","article-title":"Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women being maintained on buprenorphine during pregnancy","volume":"58","author":"O\u2019Conner","year":"2013","journal-title":"J\u00a0Midwifery Womens Health"},{"issue":"3","key":"10.1016\/j.ogc.2018.01.008_bib89","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"Transfer of drugs and other chemicals into human milk","volume":"108","year":"2001","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.ogc.2018.01.008_bib90","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/00981389.2017.1327470","article-title":"A\u00a0parenting education program for women in treatment for opioid-use disorder at an outpatient medical practice","volume":"56","author":"Kahn","year":"2017","journal-title":"Soc Work Health Care"},{"key":"10.1016\/j.ogc.2018.01.008_bib91","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ypmed.2015.04.008","article-title":"Contraceptive use and method choice among women with opioid and other substance use disorders: a systematic review","volume":"80","author":"Terplan","year":"2015","journal-title":"Prev Med"},{"key":"10.1016\/j.ogc.2018.01.008_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2017.07.167","article-title":"Knowledge of and concerns about long-acting reversible contraception among women in medication\u2013assisted treatment for opioid use disorder","author":"Matusiewicz","year":"2017","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.ogc.2018.01.008_bib93","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/AOG.0000000000002093","article-title":"Patterns of opioid prescription and use after cesarean delivery","volume":"130","author":"Bateman","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2018.01.008_bib94","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/AOG.0000000000002095","article-title":"Postdischarge opioid use after cesarean delivery","volume":"130","author":"Osmundson","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2018.01.008_bib95","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/AOG.0000000000002094","article-title":"A\u00a0shared decision-making intervention to guide opioid prescribing after cesarean delivery","volume":"130","author":"Prabhu","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ogc.2018.01.008_bib96","doi-asserted-by":"crossref","first-page":"242","DOI":"10.15585\/mmwr.mm6609a2","article-title":"CDC grand rounds: public health strategies to prevent neonatal abstinence syndrome","volume":"66","author":"Ko","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ogc.2018.01.008_bib97","unstructured":"Wisconsin Medical Examining Board Opioid Prescribing Guideline \u2013 November 16, 2016. 2016. State of Wisconsin Department of Safety and Professional Services. Available at: www.dsps.wi.gov\/Documents\/Board%20Services\/Other%20Resources\/MEB\/20161116_MEB_Guidelines_v4.pdf. Accessed August 11, 2017."},{"key":"10.1016\/j.ogc.2018.01.008_bib98","unstructured":"Centers for Disease Control and Prevention (CDC). CDC guidelines for prescribing opioids for chronic pain \u2013 United States, 2016. Centers for Disease Control and Prevention. 2016. Available at: www.cdc.gov\/mmwr\/volumes\/65\/rr\/rr6501e1.htm. Accessed September 8, 2017."},{"issue":"9","key":"10.1016\/j.ogc.2018.01.008_bib99","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s40265-016-0582-3","article-title":"Ongoing pharmacological management of chronic pain in pregnancy","volume":"76","author":"Kallen","year":"2016","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.ogc.2018.01.008_bib100","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/1552-6909.12487","article-title":"Safe management of chronic pain in the pregnancy in an era of opioid misuse and abuse","volume":"43","author":"Pritham","year":"2014","journal-title":"J\u00a0Obstet Gynecol Neonatal Nurs"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854518300081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854518300081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T10:02:16Z","timestamp":1660644136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854518300081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0889854518300081"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2018.01.008","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid Use Disorders and Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2018.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}